EU ministers backed a joint negotiating position on the Critical Medicines Act agreement, but some consider it a missed opportunity.
This afternoon (2 December), the Council agreed its “general approach” to the Critical Medicines Act (CMA), which aims to tackle shortages and improve the security of supply by re-shoring or friend-shoring the production of critical medicines within the EU.
Danish Health Minister and Minister for the Interior, Sophie Løhde, described the agreement as “an important step” towards ensuring that European patients have access to the medicines they need: “The Critical Medicines Act will…
